Article
Using epidemiology and archaeology to unearth new drug targets for rheumatoid arthritis therapy.
Drug discovery today - 1 Jan 2006
Mobley James L
Abstract excerpt
Epidemiological and archaeological evidence suggests that RA could be a consequence of enhanced immunity to Mycobacterium tuberculosis, and that by understanding this connection, new RA drug targets may be uncovered.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
